Abbott Labs (ABT) PT Raised to $145 at Jefferies
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/9/2026
- S&P closes at record high as soft jobs report eases rate-hike concerns
- US suffers unexpected job losses in July, markets dial back rate hike expectations
- Brent climbs $1 on uncertainty over end to Iran war
- Atlassian results seen as 'game changer' for AI kills software worries
- The Trade Desk hit by Wall St downgrades after disappointing Q2 results, outlook
- Citi cuts Micron stock target, sees memory chip prices peaking in 2Q27
- S&P closes at record high as soft jobs report eases rate-hike concerns
- Atlassian results seen as 'game changer' for AI kills software worries
- US suffers unexpected job losses in July, markets dial back rate hike expectations
- Microsoft only US hyperscaler with positive free cash flow as AI capex bites
- After-Hours Movers: TEAM, NET, TWLO, DOCS, FROG, DV, TTD, ABNB, DKNG, SG, RKT
- After-Hours Stock Movers: WDC, SNDK, FIG, APP, HUBS, SOUN, DASH, XYZ, Z, FLNC
- After-Hours Movers: SPCX, AMD, ANET, PINS, APPS, UPST, ZETA, BKNG, LCID, CPNG, MTCH
- After-Hours Stock Movers: PLTR, SNAP, ON, ICHR, WGS, WHR
- After-Hours Stock Movers: AAPL, AMZN, COIN, RBLX, RDDT, AXTI, FND, WU, GDDY
Abbott Labs (ABT) PT Raised to $134 at Raymond James
October 21, 2021 7:21 AM EDTRaymond James analyst Jayson Bedford raised the price target on Abbott Labs (NYSE: ABT) to $134.00 (from $128.00) while maintaining a Outperform rating.... More
Abbott Labs (ABT) PT Raised to $141 at Citi
October 21, 2021 5:43 AM EDTCiti analyst Joanna Wuensch raised the price target on Abbott Labs (NYSE: ABT) to $141.00 (from $140.00) while maintaining a Buy rating.... More
Abbott Labs (ABT) PT Raised to $146 at Morgan Stanley
October 21, 2021 4:36 AM EDTMorgan Stanley analyst Cecilia Furlong raised the price target on Abbott Labs (NYSE: ABT) to $146.00 (from $136.00) while maintaining a Overweight rating.... More
Abbott Labs (ABT) PT Raised to $143 at BTIG, Following Earnings
October 20, 2021 2:27 PM EDTBTIG analyst Marie Thibault raised the price target on Abbott Labs (NYSE: ABT) to $143.00 (from $136.00) while maintaining a Buy rating.
... MoreAbbott raises annual earnings outlook as COVID-19 test sales rebound
October 20, 2021 7:36 AM EDTBy Mrinalika Roy and Carl O'Donnell
(Reuters) - Abbott Laboratories said demand for its COVID-19 tests, especially rapid testing, rebounded as the U.S. wrestled with surging coronavirus cases during the quarter, prompting the company to raise its earnings forecast for the year.
The medical device maker's shares rose 3.5% to $123.53 on Wednesday after it also reported third-quarter earnings above analysts' estimates.
The company said it shipped more than 225 million COVID-19 tests globally in... More
Abbott (ABT) Tops Q3 EPS by 47c, Sales Beat
October 20, 2021 7:32 AM EDTAbbott (NYSE: ABT) reported Q3 EPS of $1.40, $0.47 better than the analyst estimate of $0.93. Revenue for the quarter came in at $10.9 billion versus the consensus estimate of $9.44 billion.
GUIDANCE:
Abbott sees FY2021 EPS of $5.00-$5.10, versus the consensus of $4.45.
For earnings history and earnings-related data on Abbott (ABT) click here.
... More